Advertisement

Author: Rylee Wilson

The FDA's Psychopharmacologic Drugs Advisory Committee will consider whether to recommend approval for a psychedelic treatment for post-traumatic stress disorder. 

Hyper-awareness of mental health conditions could be harming kids' well-being, researchers said in a May 6 report from The New York Times report. 

Advertisement
Advertisement